Indian manufacturer of AstraZeneca vaccine supplied first

Indian manufacturer of AstraZeneca vaccine “supplied to India first”
“Supply 100 million doses to the Indian government over the next two months…can export afterwards”

(Seoul = Yonhap News) Reporter Hoon-Sang Kang = CEO Adar Funawala of Indian vaccine manufacturer Serum Institute (SII) said on the 3rd that he will focus on supplying a new coronavirus infection (Corona 19) vaccine to his country. ) Revealed.
SII is a company that has conducted clinical trials in India and produces a Corona 19 vaccine developed by British pharmaceutical companies AstraZeneca and Oxford University.
According to Reuters, CEO Funawala said, “We will focus on meeting India’s immediate demand, rather than exporting the vaccines produced by SII to other countries that are interested in it over the next two months.”
“Vaccine exports can only be achieved after filling the initial supply of 100 million doses to the Indian government.” I support it.”
It also predicted that it could supply 300 million doses to the Indian government by July and August.
However, he added that a formal contract has not yet been signed with the Indian government for the supply of vaccines and is likely to be reached in a few days.
Regarding the vaccination method, the CEO of Funawala suggested, “It is recommended that the second dose is recommended 8 to 10 weeks after the first dose.”
The Indian government approved AstraZeneca’s use of the COVID-19 vaccine on the 2nd. Under the approval, the vaccine will be given as early as this week.
It is known that SII has already finished producing 50 million doses in preparation for approval.
[email protected]
(End)

<저작권자(c) 연합뉴스, 무단 전재-재배포 금지>